REGENERA Research Group

International Journal of Inflammation, Cancer and Integrative Therapy

Study of Plasma End statin Level in Patients with Acute Myeloid Leukaemia

Abstract

Author(s): Dr. Haggag R, Hussein O, El Moaty HA, Omran A and Ebian H Egypt

Endostatin is a broad spectrum angiogenesis inhibitor and may interfere with the
proangiogenic action of growth factors. Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy
characterized by accumulation of immature malignant myeloid cells in the bone
marrow and blood due to their clonal proliferation without substantial maturation